Clinical trial • Oncology
Clinical trial in Cervical cancer
Clinical trial for Cervical cancer. 20 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Cervical cancer
Key dates
- Initial CTIS Submission Date
- 09-10-2025
- First CTIS Authorization Date
- 09-03-2026
Trial design
Clinical trial across 1 site in Sweden.
- Target Sample Size
- 20
Eligibility
Recruits 20 No vulnerable populations selected (isVulnerablePopulationSelected: false)..
- Vulnerable Population
- No vulnerable populations selected (isVulnerablePopulationSelected: false).
Recruitment
- Planned Sample Size
- 20
- Recruitment Window Months
- 108
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 20
Sweden
- Earliest CTIS Part Ii Submission Date
- 13-11-2025
- Latest Decision Or Authorization Date
- 09-03-2026
- Processing Time Days
- 116
- Number Of Sites
- 1
- Number Of Participants
- 20
Sites
- Site Name
- Karolinska University Hospital
- Department Name
- Pelvic Cancer
- Contact Person Name
- Emelie Wallin
- Contact Person Email
- emelie.wallin@regionstockholm.se
- Number Of Participants
- 20
Sponsor
Primary sponsor
- Full Name
- Karolinska Institutet
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Sweden
Related trials
Other published trials that may interest you.
- Clinical trial in Cervical cancer
- ESTRIOL for Cervical cancer
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer